Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1998-11-04
2000-01-18
Leary, Louise N.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4242801, 424 111, 514110, 514114, 514 75, 514137, A61K 3900, A61K 4500, A61K 5100
Patent
active
060155639
ABSTRACT:
A polyphosphazene polyelectrolyte immunoadjuvant having improved water solubility, a vaccine composition of the immunoadjuvant and an antigen or immunogen and methods of their use in producing or enhancing an immunoprotective response in a host are disclosed.
REFERENCES:
patent: 5284934 (1994-02-01), Allen, Jr.
patent: 5494673 (1996-02-01), Adrianov et al.
patent: 5855895 (1999-01-01), Andrianov et al.
Cohen, et al., J. Am. Chem. Soc., vol. 112, pp. 7832-7833 (1990).
Andrianov, et al., J. Controlled Release, vol. 27, pp. 69-77 (1993).
Andrianov Alexander K.
Payne Lendon G.
Sargent Jonathan R.
Sule Sameer S.
AVANT Immunotherapeutics, Inc.
Leary Louise N.
Lillie Raymond J.
Olstein Elliot M.
LandOfFree
Polyphosphazene polyelectrolyte immunoadjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyphosphazene polyelectrolyte immunoadjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyphosphazene polyelectrolyte immunoadjuvants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-561211